Important Announcement for Hong Kong Stocks.
1) Company News
$HKT-SS (06823.HK)$The mid-term performance report shows that total revenue increased by 2% to HKD 16.669 billion, and net income increased by 2% to HKD 1.99 billion.
$EB SECURITIES (06178.HK)$Revenue for the first half of the year was CNY 4.2 billion, a year-on-year decrease of 32.03%; net income attributable to shareholders was CNY 1.391 billion, a year-on-year decrease of 41.87%.
$WL DELICIOUS (09985.HK)$Net income for the first half of the year is expected to be between CNY 0.5991 billion and CNY 0.6215 billion, a year-on-year increase of approximately 34% to 39%.
$FENBI (02469.HK)$Revenue for the first half of the year is expected to be no less than CNY 1.61 billion, and net income is expected to be no less than CNY 0.255 billion, a year-on-year increase of no less than 212.9%.
$GUSHENGTANG (02273.HK)$Revenue for the first half of the year is expected to be between CNY 1.331 billion and CNY 1.381 billion, a year-on-year increase of approximately 35% to 40%; net income is expected to be between CNY 0.103 billion and CNY 0.108 billion, an increase of approximately 11% to 16%.
$CHINA SANJIANG (02198.HK)$Net profit for the first half of the year was CNY 0.15 billion, a year-on-year increase of over 400%.
$DAPHNE INT'L (00210.HK)$Net profit for the first half of the year is expected to be no less than CNY 50 million, a year-on-year increase of no less than 62%.
$EAST BUY (01797.HK)$Dong Yuhui resigns; attached Beijing New Oriental Xun Cheng Network Technology plans to sell 100% equity of Huitongxing (Beijing) Technology to Dong Yuhui for CNY 76.5855 million; intends to repurchase no more than CNY 0.5 billion of the company's shares.
$BOAN BIOTECH (06955.HK)$The self-developed innovative antibody-drug conjugate (ADC) injection drug BA1302 has been approved for clinical trials for the treatment of advanced solid tumors. This product is the first innovative ADC candidate drug targeting CD228 approved to enter the clinical stage in China.
$BAY AREA DEV (00737.HK)$In June, total toll revenue for Guangzhou-Shenzhen Expressway was CNY 0.254 billion, a year-on-year increase of 5%; total toll revenue for Guangzhou-Zhuhai West Expressway was CNY 0.115 billion, a year-on-year increase of 6%; total toll revenue for Shenzhen section of Yanjiang Expressway was CNY 54.7 million, a year-on-year increase of 2%.
$WASION HOLDINGS (03393.HK)$In July 2024, Whess Group Limited, a wholly-owned subsidiary, won intelligent metering contracts worth approximately USD 9.42 million and approximately USD 5.74 million in the Singapore and Malaysian markets, respectively.
$MINMETALS LAND (00230.HK)$Received a revolving loan facility of HKD 1.8 billion.
$DIDA INC (02559.HK)$The stabilization period has ended, and the over-allotment rights have expired.
2) Repurchase Dynamics
$MEITUAN-W (03690.HK)$Repurchased 4.6 million shares for HKD 0.495 billion at a buyback price of HKD 106.3 to HKD 111.4.
$AIA (01299.HK)$Repurchased 8.179 million shares for HKD 0.419 billion at a buyback price of HKD 50.85 to HKD 51.8.
$HSBC HOLDINGS (00005.HK)$Spending 0.167 billion Hong Kong dollars to repurchase 2.5 million shares at a repurchase price of 66.40-67.05 Hong Kong dollars.
$CNOOC (00883.HK)$Spending 98.0982 million Hong Kong dollars to repurchase 4.878 million shares at a repurchase price of 19.68-20.5 Hong Kong dollars.
Editor/new